“Kisspeptin-10”的搜索结果，显示 51-60 项，共有 6064 项

1. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

2. 乳腺专科门诊- 临床试验- 妙佑医疗国际

   June 10, 2026. Share on: FacebookTwitter WeChat. WeChat. Close. Weibo. 乳腺专科门诊. 部分. 申请预约 · 概述 · 测试与程序 · 主治 · 医生 · 医生（按院区及专科分类） ...

3. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

4. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

5. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

6. Mayo Clinic Endocrinology Physician Update - August 2026

   Page 1.

7. 血液科- 临床试验- 妙佑医疗国际

   A selected subset of participants (10 survivors and 10 caregivers) will be ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... (10) advanced, unresectable multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with ...

9. 神经科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

10. 神经科- 临床试验- 妙佑医疗国际

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...